Duality Advisers LP purchased a new position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 155,267 shares of the company’s stock, valued at approximately $1,621,000. Other institutional investors also recently bought and […]
Element Wealth LLC lifted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 394.8% during the fourth quarter, Holdings Channel reports. The firm owned 65,740 shares of the company’s stock after buying an additional 52,454 shares during the period. Element Wealth LLC’s holdings in Teva Pharmaceutical Industries were worth $686,000 […]
Element Wealth LLC increased its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 394.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 65,740 shares of the company’s stock after purchasing an additional 52,454 shares during the quarter. Element Wealth […]
Recently, the Australian Therapeutic Goods Administration (TGA) approved Winlevi (clascoterone cream 1%), a product of Sun Pharma, for treating acne Vulgaris in patients aged 12 and above.
Tobam lowered its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 6.2% in the fourth quarter, HoldingsChannel.com reports. The fund owned 362,069 shares of the company’s stock after selling 23,827 shares during the quarter. Tobam’s holdings in Teva Pharmaceutical Industries were worth $3,780,000 at the end of the most recent […]